Scientific article

NT-proBNP is a potential mediator between reduced ejection fraction and depression in patients with heart failure

Journal of Psychiatric Research · · Pedro Zuzarte, first author (with 5 co-authors)

Image from the original publication: “NT-proBNP is a potential mediator between reduced ejection fraction and depression in patients with heart failure”

An original article published in the Journal of Psychiatric Research in 2018, with Pedro Zuzarte as first author and data collected in Canada. It studies 124 patients with chronic heart failure and proposes NT-proBNP as a possible mediator between reduced ejection fraction and depressive symptoms.

Key ideas

  • First author; research linked to his PhD.
  • Links a cardiac biomarker to depressive symptoms.
  • Contributes to the hypothesis of shared pathophysiological pathways between the heart and mood.
Read more

Background

Depression and anxiety are common in patients with heart failure. Reduced ejection fraction and raised NT-proBNP (N-terminal prohormone of B-type natriuretic peptide) had already been independently associated with depressive symptoms and may contribute to disease progression and mortality. The study assessed whether NT-proBNP mediates the effect of reduced ejection fraction on depressive and anxiety symptoms.

Methods

The participants were 124 patients with a diagnosis of chronic heart failure enrolled in the Heart Failure Disease Management Program at Health Sciences North, in Sudbury, Canada. Depressive and anxiety symptoms were assessed at enrolment with the Hospital Anxiety and Depression Scale (HADS). Ejection fraction, measured by multigated acquisition (MUGA) scanning, and NT-proBNP, measured by chemiluminescent immunoassay, were obtained at baseline. Patients were followed for 12 months. Regression and multivariate models were used, with mediation analysis for indirect effects.

Main results

  • Ejection fraction and NT-proBNP were highly correlated.
  • There was no significant direct effect of ejection fraction on depressive or anxiety symptoms.
  • There was a significant indirect effect of ejection fraction on depression, mediated by NT-proBNP levels; this was not the case for anxiety.

Clinical implications

The authors conclude that NT-proBNP is a potential mechanism linking reduced ejection fraction and depressive symptoms in heart failure. They stress that the results are preliminary, but suggest that NT-proBNP may help to identify patients with reduced ejection fraction at higher risk of depression, disease progression and mortality.

Reference

Zuzarte P, Scola G, Duong A, Kostiw K, Figueira ML, Costa-Vitali A. NT-proBNP is a potential mediator between reduced ejection fraction and depression in patients with heart failure. J Psychiatr Res. 2018 Sep;104:8-15. DOI: 10.1016/j.jpsychires.2018.06.010. PMID: 29913350.

A psychiatric assessment can be the first step.

Book an appointment

How a consultation works

If you are looking for psychedelic therapy, KETAMED is the clinic dedicated to this field.

Discover KETAMED (opens in a new tab)

Follow KETAMED: Instagram (opens in a new tab) · Facebook (opens in a new tab)